Showing results (211-220 of 362) with videos related to
Sort By:
Pageof 37
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1987
Functional analysis of T lymphocyte subsets in antiviral host defenseT P Leist, S P Cobbold, H Waldmann, et al.Transplantation|November 26, 1999
Anti-globulin responses to rat and humanized CAMPATH-1 monoclonal antibody used to treat transplant rejectionP R Rebello, G Hale, P J Friend, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 7, 2012
Th17 cells induce a distinct graft rejection response that does not require IL-17AE I Agorogiannis, F S Regateiro, D Howie, et al.British Journal of Haematology|July 1, 1993
CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpuraS H Lim, G Hale, R E Marcus, et al.Transplantation|October 27, 1995
The effect of aglycosylation on the immunogenicity of a humanized therapeutic CD3 monoclonal antibodyE G Routledge, M E Falconer, H Pope, et al.Immunological Reviews|February 1, 1996
Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8S P Cobbold, E Adams, S E Marshall, et al.Journal of the American Chemical Society|July 18, 2001
Synthesis of functional Ras lipoproteins and fluorescent derivativesK Kuhn, D J Owen, B Bader, et al.Bone Marrow Transplantation|December 12, 2002
Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?G Hale, S Slavin, J M Goldman, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1996
T cell suppression in transplantation tolerance through linked recognitionJ D Davies, L Y Leong, A Mellor, et al.Cellular Immunology|September 1, 1989
Depletion of L3T4+ and Lyt-2+ cells by rat monoclonal antibodies alters the development of adoptively transferred experimental autoimmune thyroiditisJ C Flynn, D H Conaway, S Cobbold, et al.Pageof 37